The HHS has released documents confirming its recommendation that cannabis be rescheduled as a lower risk drug.
The event will be held on Wednesday, 28 March to mark the end of Women’s History Month
There is currently only one consultant who specialises in paediatric epilepsy prescribing cannabis in the UK
The webinar marks the first in a series of week-long events featuring patient's experiences of cannabis-based medicines and access
MGC Pharma has become the first medicinal cannabis company in history to list on the London Stock Exchange. The European based and Australian listed bio-pharma company,...
A German cannabis flower harvester is said to drastically reduce costs and speed up cannabis cultivation. German developer, HHH Hemp Harvesting Technology, said a cost analysis...
Plant doctor and cannabis expert, Dr Callie Seaman answers some of the common questions about medical cannabis and explains how pharmaceutical products differ from those found...
More than half of people who use medical cannabis products to ease pain experience withdrawal symptoms between uses, a new study finds. Around 10% of the...
It’s not as simple as swapping children from one cannabis product to another – consistency is key in the treatment of severe epilepsy, warn experts. Dozens...
The Health Secretary says he is working with the Dutch government to ensure patients with severe epilepsy can still access medical cannabis. Health Secretary Matt Hancock...
